Immunothérapie des cancers par anticorps anti-PD-1

Marion V. Guérin(Inserm), Philippe Bousso(Inserm), Mathilde Ruggiu(Inserm)

médecine/sciences

August 1, 2024

10.1051/medsci/2024088

Cited by 0

Related Papers

Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease

|Science|2000|2.6k

Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment

|Proceedings of the National Academy of Sciences|2018|948

Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes

|Nature Immunology|2003|617

Preclinical murine tumor models: A structural and functional perspective

|eLife|2020|140

Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity

|Nature Cancer|2023|137